CBR Scientific Advisory Board
A world-class group of scientists supplies an invaluable third-party perspective on CBR’s current and future research.
CBR´s Scientific Advisory Board (SAB) has an essential role in ensuring the high scientific quality and sustainability of CBR. Its members pay annual visits to the institute, advise, suggest, or recommend the CBR Direction on:
-
Institutional scientific objectives and strategy;
-
Institutional activities and functioning;
-
Institutional annual report;
-
Recruitment and evaluation of principal investigators.
The current CBR SAB is composed of five leading international biomedical research and science policy experts:
-
Maria da Graça Raposo, Centre National de la Recherche Scientifique (CNRS) Research Director, CNRS Advanced Education Director, Institute Curie, Paris, France - CBR SAB President
-
Christine Durinx, Co-managing director, Vlaams Institute for Biotechnology, VIB, Flanders, Belgium
-
Farhana Alarakhiya, Chief Data Innovation Officer, Aga Khan University, London, United Kingdom
-
Pavel Tomancak, Senior Research Group Leader, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany and CEITEC Consortium, Brno, Czech Republic
-
Nassos Typas, Group Leader and Senior Scientist, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
CBR directors first met with the SAB online to present the CBR and its strategic plan on February 2, 2023, and held the first in-person meeting on June 21-22, 2023.